Composition Containing Mixed Extract of Mulberry and Poria Cocos Peel
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/KR2015/013134, filed Dec 3, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,946,053 | Composition Containing Mixed Extract of Mulberry and Poria Cocos Bark for Preventing, Improving or Treating Neurodegenerative Disorders In force · High confidence UsedRemaining | Neurobo Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,588,927 | Composition Containing Mixed Extract of Mulberry and Poria Cocos Peel In force · High confidence | Neurobo Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 17/169,905 | Composition Containing Mixed Extract of Mulberry and Poria Cocos Bark Abandoned Abandoned Apr 27, 2023 | NeuroBo Pharmaceuticals, Inc. | Abandoned | Abandoned Apr 27, 2023 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Neurobo Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.